Peter Tonn
Overview
Explore the profile of Peter Tonn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
129
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tonn P, Seule L, Degani Y, Herzinger S, Klein A, Schulze N
JMIR Form Res
. 2022 Aug;
6(8):e37061.
PMID: 36040767
Background: Mood disorders and depression are pervasive and significant problems worldwide. These represent severe health and emotional impairments for individuals and a considerable economic and social burden. Therefore, fast and...
2.
Moritz S, Goritz A, Kraj M, Gehlenborg J, Hottenrott B, Tonn P, et al.
Eur Addict Res
. 2020 Sep;
26(6):355-364.
PMID: 32877910
Objectives: Smoking is a highly prevalent addictive behavior with severe and life-shortening health consequences. This is the first study to evaluate the efficacy of a newly developed imaginal variant of...
3.
Tonn P, Degani Y, Hershko S, Klein A, Seule L, Schulze N
JMIR Res Protoc
. 2020 May;
9(5):e13852.
PMID: 32406862
Background: The prevalence of mental disorders worldwide is very high. The guideline-oriented care of patients depends on early diagnosis and regular and valid evaluation of their treatment to be able...
4.
Schulze N, Reuter S, Kuchler I, Reinke B, Hinkelmann L, Stockigt S, et al.
Telemed J E Health
. 2018 Nov;
25(10):926-932.
PMID: 30412450
n n n t post hoc
5.
Tonn P, Reuter S, Kuchler I, Reinke B, Hinkelmann L, Stockigt S, et al.
JMIR Ment Health
. 2017 Oct;
4(4):e39.
PMID: 28974485
Background: In the field of psychiatry and psychotherapy, there are now a growing number of Web-based interventions, mobile phone apps, or treatments that are available via remote transmission screen worldwide....
6.
Moritz S, Peters M, Karow A, Deljkovic A, Tonn P, Naber D
Ment Illn
. 2014 Dec;
1(1):e2.
PMID: 25478082
Neuroleptic non-compliance remains a serious challenge for the treatment of psychosis. Non-compliance is predominantly attributed to side effects, lack of illness insight, reduced well-being or poor therapeutic alliance. However, other...
7.
Moritz S, Favrod J, Andreou C, Morrison A, Bohn F, Veckenstedt R, et al.
Schizophr Bull
. 2012 Feb;
39(4):917-22.
PMID: 22337789
Antipsychotic medication represents the treatment of choice in psychosis according to clinical guidelines. Nevertheless, studies show that half to almost three-quarter of all patients discontinue medication with antipsychotics after some...
8.
Dahmen N, Tonn P, Messroghli L, Ghezel-Ahmadi D, Engel A
Sleep
. 2009 Jul;
32(7):962-4.
PMID: 19639760
Study Objectives: We investigated basal metabolic rate (BMR) and energy expenditure (EE) in narcoleptic patients and in BMI- and age-matched controls in order to explore the hypothesis that a reduced...
9.
Tonn P, Reuter S, Hiemke C, Dahmen N
J Clin Psychopharmacol
. 2009 Jun;
29(2):191-2.
PMID: 19512989
No abstract available.
10.
Dahmen N, Becht J, Engel A, Thommes M, Tonn P
Neuropsychiatr Dis Treat
. 2008 Aug;
4(1):257-61.
PMID: 18728824
Narcoleptic patients suffer frequently from obesity and type II diabetes. Most patients show a deficit in the energy balance regulating orexinergic system. Nevertheless, it is not known, why narcoleptic patients...